Al Jazeera examines candidate malaria vaccine, other ongoing efforts to thwart the disease

NewsGuard 100/100 Score
Jan 13 2012

Al Jazeera reports on the candidate malaria vaccine known as RTS,S, which "has been heralded as one of the Top 10 Scientific Breakthroughs of 2011 by Time and Science magazines, Doctors Without Borders and the Lancet." The news service recaps the history of the vaccine's development, outlines a number of existing prevention strategies and details ongoing efforts in the global fight against malaria (Dalal, 1/11).

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Disease/Infection News | Healthcare News

    Tags: , , ,

    Comments (0)

    Suggested Reading

    ChatGPT could be an effective tool to help reduce vaccine hesitancy
    New malaria vaccine strain shows promise in preclinical trials
    The path to a better tuberculosis vaccine runs through Montana
    Oxford University and Brazil partner to advance malaria vaccine development
    Oral spray-based vaccine is a potential alternative to antibiotic treatments for recurrent UTIs
    Study shows potential for universal flu vaccine with broad antibody response
    Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook
    New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    Novel vaccine approach effective against all virus strains